US BANCORP \DE\

Holdings History for BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0

Investment type: Debt / NOTE 0.599% 8/0

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
30 Sep 2024		-0%	$0	0	-73,000	-100%		Q3 2024
30 Jun 2024	0%	0%	$72,401	73,000	0		99.18%	Q2 2024
31 Mar 2024	0%	0%	$71,679	73,000	0		98.19%	Q1 2024
31 Dec 2023	0%	0%	$71,949	73,000	0		98.56%	Q4 2023
30 Sep 2023	0%	0%	$70,810	73,000	0		97.0%	Q3 2023
30 Jun 2023	0%	0%	$71,706	73,000	0		98.23%	Q2 2023
31 Mar 2023	0%	0%	$74,897	73,000	0		102.6%	Q1 2023
31 Dec 2022	0%	0%	$77,475	73,000	0		106.13%	Q4 2022
30 Sep 2022	0%	0%	$72,000	73,000	0		98.63%	Q3 2022
30 Jun 2022	0%	+0%	$72,000	73,000	+73,000	NEW	98.63%	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.